Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non‐transfusion‐dependent thalassaemia-Reference-Cited by-同舟云学术

Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non‐transfusion‐dependent thalassaemia

Published:2014-09-12 Issue:2 Volume:168 Page:284-290
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Taher Ali T.¹,Porter John B.²,Viprakasit Vip³,Kattamis Antonis⁴,Chuncharunee Suporn⁵,Sutcharitchan Pranee⁶,Siritanaratkul Noppadol⁷,Origa Raffaella⁸,Karakas Zeynep⁹,Habr Dany¹⁰,Zhu Zewen¹⁰,Cappellini Maria Domenica¹¹

Affiliation:

1. American University of Beirut Beirut Lebanon

2. University College London London UK

3. Department of Paediatrics and Thalassemia Centre Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

4. First Department of Paediatrics University of Athens Athens Greece

5. Ramathibodi Hospital Mahidol University Bangkok Thailand

6. Chulalongkorn University and King Chulalongkorn Memorial Hospital Bangkok Thailand

7. Department of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

8. Ospedale Regional Microcitemie Cagliari Italy

9. Istanbul Medical Faculty Istanbul University Istanbul Turkey

10. Novartis Pharmaceuticals East Hanover NJ USA

11. Università di Milano Ca Granda Foundation IRCCS Milan Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.13119

Reference22 articles.

1. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia

2. Association between serum ferritin level, cardiac and hepatic T2‐star MRI in patients with major beta‐thalassemia;Eghbali A.;Iranian Journal of Pediatric Hematology Oncology,2014

3. Heterogeneity of Hemoglobin H Disease in Childhood

4. A Prospective Study of Hepatocellular Carcinoma Incidence in Thalassemia

5. Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfusional hemosiderosis in childhood cancer patients and survivors;Pediatric Blood & Cancer;2024-08-03

2. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia;Expert Review of Hematology;2024-07-26

3. Transfusion reactions in neonates and pediatrics;Asian Journal of Transfusion Science;2023-01

4. Alpha-Thalassemia: Diversity of Clinical Phenotypes and Update on the Treatment;Thalassemia Reports;2022-11-22

5. Thalassemia Intermedia: Chelator or Not?;International Journal of Molecular Sciences;2022-09-05